Athens, Greece

Nikolaos Loupis

This inventor holds 47 USPTO granted patents and 47 published patent applications, plus 15 CIPO patents and 18 EPO patents, primarily in Biophotonic Technologies. Top assignees: Klox Technologies Limited, Fle International S.r.l., Vetoquinol S.a.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolaos Loupis. Retrieved from https://idiyas.com/inventor/nikolaos-loupis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 

% Patents Active = 72.3

 

 

Average Co-Inventor Count = 2.9

ph-index = 12

Forward Citations = 362(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biophotonic Materials
Skin Treatment
Wound Healing
Photoactivatable Fibers
Phototherapy Devices
Biofilm Disruption
Energy Production
Aging Reversal
Teeth Whitening
Chromophore Compositions
Silicone-based Compositions
Oral Disinfection
47 patents (USPTO):Explore Patents

Title: Nikolaos Loupis: Innovator in Biophotonic Compositions and Skin Rejuvenation

Introduction:

Nikolaos Loupis, based in Athens, Greece, is an esteemed inventor who has made significant contributions to the field of biophotonic compositions and methods for providing biophotonic treatment. With an impressive portfolio of 44 patents, Loupis has revolutionized approaches to wound healing, skin rejuvenation, acne treatment, and various skin disorders. This article sheds light on his latest patents, career highlights, collaborations, and the impact of his innovative work.

Latest Patents:

Nikolaos Loupis continues to make groundbreaking advancements in the field of biophotonics, as evident from his recent patents. One of his latest patents is titled "Biophotonic compositions and methods for providing biophotonic treatment." This invention provides topical compositions that are resistant to leaching, ensuring that minimal amounts of chromophore(s) dissolve out of the composition. These compositions have proven beneficial in wound healing, skin rejuvenation, treating acne, and addressing different skin disorders.

Another notable invention by Loupis involves "Methods and compositions for reversing or mitigating skin aging." This patent introduces a unique method that reverses or mitigates skin aging by topically applying a specially formulated composition. This composition consists of oxidants and fluorescent dyes capable of activating the oxidants when illuminated. The resulting process facilitates the restoration and rejuvenation of the skin.

Career Highlights:

Throughout his career, Nikolaos Loupis has demonstrated exceptional expertise in the field of biophotonics and skincare. With his pioneering inventions, he has significantly impacted the medical aesthetics and dermatology sector. His patents have enabled effective treatment solutions for various skin conditions, transforming the way professionals approach wound healing and skin rejuvenation.

Collaborations:

Loupis has worked alongside esteemed professionals, including Remigio Piergallini and Francesco Bellini. His collaboration with Klox Technologies Ltd, a leader in biophotonics-based healthcare solutions, has played a pivotal role in the successful commercialization of his patented inventions. Additionally, Loupis has worked with Vetoquinol S.A., a renowned veterinary pharmaceutical company, to develop innovative solutions for animal care.

Conclusion:

Nikolaos Loupis is an exemplary innovator in the realm of biophotonic compositions and skin rejuvenation. With his extensive portfolio of 44 patents, he has been instrumental in advancing wound healing techniques and addressing various skin disorders. His inventions have not only transformed the skincare industry but have also improved the quality of life for individuals seeking effective treatment options. Loupis's collaborations with esteemed professionals and renowned companies have further contributed to the successful implementation and commercialization of his inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…